Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Signals Progress In War On Adulterated Supplements

This article was originally published in The Tan Sheet

Executive Summary

CDER data show class I recalls of supplements spiked with undeclared drug ingredients fell dramatically the past two years after peaking in fiscal 2010.

You may also be interested in...



FDA War On Tainted Supplements Wages On

A warning letter about tainted dietary supplements is a reminder that even though recalls of spiked supplements are declining, products marketed as supplements that contain undeclared prescription drugs still infiltrate the market. The letter illustrates recalling tainted supplements may not prevent future enforcement actions.

FDA War On Tainted Supplements Wages On

A warning letter about tainted dietary supplements is a reminder that even though recalls of spiked supplements are declining, products marketed as supplements that contain undeclared prescription drugs still infiltrate the market. The letter illustrates recalling tainted supplements may not prevent future enforcement actions.

Food Safety Rule Augments Dietary Supplement Supply Chain Security

A proposed rule would mandate ingredient suppliers’ compliance with tighter GMPs for traditional food product firms, as called for in the sweeping Food Safety Modernization Act.

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel